{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:03:40Z","timestamp":1781327020957,"version":"3.54.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00277-019-03776-x","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T21:41:32Z","timestamp":1566510092000},"page":"2257-2265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Association of plasma homocysteine level with vaso-occlusive crisis in sickle cell anemia patients of Odisha, India"],"prefix":"10.1007","volume":"98","author":[{"given":"Satyabrata","family":"Meher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siris","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishalaya","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehadhini","family":"Dehury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimal Prasad","family":"Jit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra M.","family":"Maske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmalaya","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bisnu Prasad","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep Kumar","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"issue":"4537","key":"3776_CR1","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/178792a0","volume":"178","author":"VM Ingram","year":"1956","unstructured":"Ingram VM (1956) A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin. Nature. 178(4537):792\u2013794","journal-title":"Nature."},{"issue":"5","key":"3776_CR2","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1182\/blood.V70.5.1245.1245","volume":"70","author":"WA Eaton","year":"1987","unstructured":"Eaton WA, Hofrichter J (1987) Hemoglobin S gelation and sickle cell disease. Blood. 70(5):1245\u20131266","journal-title":"Blood."},{"key":"3776_CR3","doi-asserted-by":"publisher","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","volume":"4","author":"GJ Kato","year":"2018","unstructured":"Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L et al (2018) Sickle cell disease. Nat Rev Dis Primers 4:18010. \n                    https:\/\/doi.org\/10.1038\/nrdp.2018.10","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"3776_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/1076029607308390","volume":"14","author":"IV Mohan","year":"2008","unstructured":"Mohan IV, Jagroop IA, Mikhailidis DP, Stansby GP (2008) Homocysteine activates platelets in vitro. Clin Appl Thromb Hemost 14(1):8\u201318. \n                    https:\/\/doi.org\/10.1177\/1076029607308390","journal-title":"Clin Appl Thromb Hemost"},{"issue":"9442","key":"3776_CR5","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/S0140-6736(04)17192-4","volume":"364","author":"MJ Stuart","year":"2004","unstructured":"Stuart MJ, Nagel RL (2004) Sickle-cell disease. Lancet 364(9442):1343\u20131360. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(04)17192-4","journal-title":"Lancet"},{"issue":"12","key":"3776_CR6","first-page":"954","volume":"39","author":"BC Kar","year":"1991","unstructured":"Kar BC (1991) Sickle cell disease in India. J Assoc Physicians India 39(12):954\u2013960","journal-title":"J Assoc Physicians India"},{"issue":"3","key":"3776_CR7","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1172\/JCI89741","volume":"127","author":"GJ Kato","year":"2017","unstructured":"Kato GJ, Steinberg MH, Gladwin MT (2017) Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest 127(3):750\u2013760. \n                    https:\/\/doi.org\/10.1172\/JCI89741","journal-title":"J Clin Invest"},{"issue":"4","key":"3776_CR8","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1172\/JCI108350","volume":"57","author":"DE Wilcken","year":"1976","unstructured":"Wilcken DE, Wilcken B et al (1976) J Clin Invest 57(4):1079\u20131082. \n                    https:\/\/doi.org\/10.1172\/JCI108350","journal-title":"J Clin Invest"},{"issue":"1","key":"3776_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/0002-9343(68)90004-1","volume":"45","author":"MC Carey","year":"1968","unstructured":"Carey MC, Fennelly JJ, FitzGerald O, Homocystinuria II (1968) Homocystinuria. II. Subnormal serum folate levels increased folate clearance and effects of folic acid therapy. Am J Med 45(1):26\u201331. Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/5658866\n                    \n                  . \n                    https:\/\/doi.org\/10.1016\/0002-9343(68)90004-1","journal-title":"Am J Med"},{"issue":"5","key":"3776_CR10","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/0026-0495(87)90043-6","volume":"36","author":"SS Kang","year":"1987","unstructured":"Kang SS, Wong PW, Norusis M (1987) Homocysteinemia due to folate deficiency. Metabolism 36(5):458\u2013462. \n                    https:\/\/doi.org\/10.1016\/0026-0495(87)90043-6","journal-title":"Metabolism"},{"issue":"1","key":"3776_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12291-011-0158-7","volume":"27","author":"S Pandey","year":"2012","unstructured":"Pandey S, Pandey HR, Mishra RM, Pandey S, Saxena R (2012) Increased homocysteine level in Indian sickle cell anemia patients. Indian J Clin Biochem 27(1):103\u2013104. \n                    https:\/\/doi.org\/10.1007\/s12291-011-0158-7","journal-title":"Indian J Clin Biochem"},{"issue":"5","key":"3776_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3122\/15572625-11-5-391","volume":"11","author":"SL Abby","year":"1998","unstructured":"Abby SL, Harris IM, Harris KM (1998) Homocysteine and cardiovascular disease. J Am Board Fam Pract 11(5):391\u2013398. \n                    https:\/\/doi.org\/10.3122\/15572625-11-5-391","journal-title":"J Am Board Fam Pract"},{"issue":"4","key":"3776_CR13","first-page":"473","volume":"10","author":"S Sati\u2019Abbas","year":"2011","unstructured":"Sati\u2019Abbas S, Abul\u2013Razak N, Mustafa N, Ali RA (2011) Homocysteine, folic acid, vitamin B12 and pyridoxine: effects on vaso-occlusive crisis in sickle cell anemia and sickle\u2013thalassemia. Iraqi Acad Sci J 10(4):473\u2013479 \n                    https:\/\/www.iasj.net\/iasj?func=article&aId=43573","journal-title":"Iraqi Acad Sci J"},{"issue":"1","key":"3776_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.nut.2005.04.012","volume":"22","author":"F Luo","year":"2006","unstructured":"Luo F, Liu X, Wang S, Chen H (2006) Effect of homocysteine on platelet activation induced by collagen. Nutrition 22(1):69\u201375. \n                    https:\/\/doi.org\/10.1016\/j.nut.2005.04.012","journal-title":"Nutrition"},{"issue":"5","key":"3776_CR15","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/j.1538-7836.2007.02459.x","volume":"5","author":"A Undas","year":"2007","unstructured":"Undas A, Stepie\u0144 E, Plicner D, Zielinski L, Tracz W (2007) Elevated total homocysteine is associated with increased platelet activation at the site of microvascular injury: effects of folic acid administration. J Thromb Haemost 5(5):1070\u20131072. \n                    https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02459.x","journal-title":"J Thromb Haemost"},{"issue":"5","key":"3776_CR16","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/07315724.2000.10718958","volume":"19","author":"EA Lowenthal","year":"2000","unstructured":"Lowenthal EA, Mayo MS, Cornwell PE, Thornley-Brown D (2000) Homocysteine elevation in sickle cell disease. J Am Coll Nutr 19(5):608\u2013612. \n                    https:\/\/doi.org\/10.1080\/07315724.2000.10718958","journal-title":"J Am Coll Nutr"},{"issue":"3","key":"3776_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4103\/ejh.ejh_1_18","volume":"43","author":"AA Raouf","year":"2018","unstructured":"Raouf AA, Hamdy MM, Badr AM, Shalaan O, Sakr M, Rahman AR (2018) Effect of homocysteine and folic acid on vaso-occlusive crisis in children with sickle cell disease. Egypt J Haematol 43(3):115\u2013118","journal-title":"Egypt J Haematol"},{"issue":"22","key":"3776_CR18","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","volume":"277","author":"IM Graham","year":"1997","unstructured":"Graham IM, Daly LE, Refsum HM, Robinson K, Brattstr LE, Ueland PM et al (1997) Plasma homocysteine for vascular disease. JAMA 277(22):1775\u20131781. \n                    https:\/\/doi.org\/10.1001\/jama.1997.03540460039030","journal-title":"JAMA"},{"issue":"2","key":"3776_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11883-006-0046-4","volume":"8","author":"S Guthikonda","year":"2006","unstructured":"Guthikonda S, Haynes WG (2006) Homocysteine: role and implications in atherosclerosis. Curr Atheroscler Rep 8(2):100\u2013106. \n                    https:\/\/doi.org\/10.1007\/s11883-006-0046-4","journal-title":"Curr Atheroscler Rep"},{"issue":"4","key":"3776_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0165-6147(00)01675-8","volume":"22","author":"PM Ueland","year":"2001","unstructured":"Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE (2001) Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 22(4):195\u2013201. Available from: \n                    http:\/\/tips.trends.com\n                    \n                  . \n                    https:\/\/doi.org\/10.1016\/S0165-6147(00)01675-8","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"3776_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10(1):111\u2013113. \n                    https:\/\/doi.org\/10.1038\/ng0595-111","journal-title":"Nat Genet"},{"key":"3776_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bcmd.2018.12.003","volume":"75","author":"BP Jit","year":"2019","unstructured":"Jit BP, Mohanty PK, Purohit P, Das K, Patel S, Meher S, Mohanty JR, Sinha S, Behera RK, Das P (2019) Association of fetal hemoglobin level with frequency of acute pain episodes in sickle cell disease (HbS-only phenotype) patients. Blood Cells Mol Dis 75:30\u201334","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"3776_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1600-0609.2009.01290.x","volume":"83","author":"RS Mashon","year":"2009","unstructured":"Mashon RS, Dash PM, Khalkho J, Dash L, Mohanty PK, Patel S, Mohanty RC, Das BS, Das UK, Das PK, Patel DK (2009) Higher fetal hemoglobin concentration in patients with sickle cell disease in eastern India reduces frequency of painful crisis. Eur J Haematol 83(4):383\u2013384","journal-title":"Eur J Haematol"},{"issue":"4","key":"3776_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1365-2141.2005.05411.x","volume":"129","author":"MH Steinberg","year":"2005","unstructured":"Steinberg MH (2005) Predicting clinical severity in sickle cell anaemia. Br J Haematol 129(4):465\u2013481","journal-title":"Br J Haematol"},{"issue":"1","key":"3776_CR25","first-page":"288","volume":"91","author":"K Ohene-Frempong","year":"1998","unstructured":"Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW et al (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 91(1):288\u2013294","journal-title":"Blood."},{"issue":"1","key":"3776_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJM199107043250103","volume":"325","author":"OS Platt","year":"1991","unstructured":"Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR (1991) Pain in sickle cell disease: rates and risk factors. N Engl J Med 325(1):11\u201316","journal-title":"N Engl J Med"},{"issue":"4","key":"3776_CR27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/adc.67.4.517","volume":"67","author":"K Bailey","year":"1992","unstructured":"Bailey K, Morris JS, Thomas P, Serjeant GR (1992) Fetal haemoglobin and early manifestations of homozygous sickle cell disease. Arch Dis Child 67(4):517\u2013520","journal-title":"Arch Dis Child"},{"issue":"9861","key":"3776_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","volume":"381","author":"FB Piel","year":"2013","unstructured":"Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M et al (2013) Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 381(9861):142\u2013151. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(12)61229-X","journal-title":"Lancet"},{"issue":"1","key":"3776_CR29","doi-asserted-by":"publisher","first-page":"17685","DOI":"10.1038\/s41598-018-36077-w","volume":"8","author":"C Hockham","year":"2018","unstructured":"Hockham C, Bhatt S, Colah R, Mukherjee MB, Penman BS, Gupta S et al (2018) The spatial epidemiology of sickle-cell anaemia in India. Sci Rep 8(1):17685. \n                    https:\/\/doi.org\/10.1038\/s41598-018-36077-w","journal-title":"Sci Rep"},{"issue":"2","key":"3776_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00062752-200203000-00006","volume":"9","author":"D Mohanty","year":"2002","unstructured":"Mohanty D, Mukherjee MB (2002) Sickle cell disease in India. Curr Opin Hematol 9(2):117\u2013122","journal-title":"Curr Opin Hematol"},{"key":"3776_CR31","first-page":"19","volume":"6","author":"DK Patel","year":"2010","unstructured":"Patel DK, Mashon RS, Patel S (2010) Epidemiology and clinical aspects of sickle cell disease in India. Orissa Phys J 6:19\u201323","journal-title":"Orissa Phys J"},{"issue":"6","key":"3776_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0197-2456(95)00098-4","volume":"16","author":"S Charache","year":"1995","unstructured":"Charache S, Terrin ML, Moore RD, Dover GJ, McMahon RP, Barton FB et al (1995) Investigators of the multicenter study of hydroxyurea. Design of the multicenter study of hydroxyurea in sickle cell anemia. Control Clin Trials 16(6):432\u2013446. \n                    https:\/\/doi.org\/10.1016\/S0197-2456(95)00098-4","journal-title":"Control Clin Trials"},{"issue":"3","key":"3776_CR33","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1191\/0269216304pm897ed","volume":"18","author":"C Reid","year":"2004","unstructured":"Reid C, Davies A (2004) The World Health Organization three-step analgesic ladder comes of age. Palliat Med 18(3):175\u2013176. \n                    https:\/\/doi.org\/10.1191\/0269216304pm897ed","journal-title":"Palliat Med"},{"issue":"5","key":"3776_CR34","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1046\/j.1365-2141.2003.04193.x","volume":"120","author":"DC Rees","year":"2003","unstructured":"Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J (2003) Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haematol 120(5):744\u2013752","journal-title":"Br J Haematol"},{"issue":"6","key":"3776_CR35","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jpainsymman.2010.03.020","volume":"40","author":"SK Ballas","year":"2010","unstructured":"Ballas SK, Bauserman RL, McCarthy WF, Castro OL, Smith WR, Waclawiw MA (2010) Investigators of the multicenter study of hydroxyurea in sickle cell anemia. Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home. J Pain Symptom Manag 40(6):870\u2013882","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"3776_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev.nu.12.070192.001431","volume":"12","author":"SS Kang","year":"1992","unstructured":"Kang SS, Wong PW, Malinow MR (1992) Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 12(1):279\u2013298. \n                    https:\/\/doi.org\/10.1146\/annurev.nu.12.070192.001431","journal-title":"Annu Rev Nutr"},{"issue":"1","key":"3776_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1373\/clinchem.2003.021634","volume":"50","author":"H Refsum","year":"2004","unstructured":"Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J et al (2004) Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 50(1):3\u20132","journal-title":"Clin Chem"},{"key":"3776_CR38","first-page":"74","volume-title":"The Thalassemias","author":"JM Old","year":"1983","unstructured":"Old JM, Higgs DR (1983) Gene analysis. Methods in haematology. In: Weatherall DJ (ed) The Thalassemias. Churchill & Livingstone, Edinburgh, p 74"},{"issue":"15","key":"3776_CR39","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","volume":"22","author":"X Sol\u00e9","year":"2006","unstructured":"Sol\u00e9 X, Guin\u00f3 E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22(15):1928\u20131929. \n                    https:\/\/doi.org\/10.1093\/bioinformatics\/btl268","journal-title":"Bioinformatics"},{"issue":"1","key":"3776_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1365-2141.2001.02557.x","volume":"112","author":"GR Serjeant","year":"2001","unstructured":"Serjeant GR (2001) The emerging understanding of sickle cell disease. Br J Haematol 112(1):3\u201318. \n                    https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02557.x","journal-title":"Br J Haematol"},{"issue":"2","key":"3776_CR41","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1467-3010.2005.00467.x","volume":"30","author":"F Phillips","year":"2005","unstructured":"Phillips F (2005) Vegetarian nutrition. Nutr Bull 30(2):132\u2013167. \n                    https:\/\/doi.org\/10.1111\/j.1467-3010.2005.00467.x","journal-title":"Nutr Bull"},{"issue":"3","key":"3776_CR42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3109\/00365518809167487","volume":"48","author":"LE Brattstr\u00f6m","year":"1988","unstructured":"Brattstr\u00f6m LE, Israelsson B, Jeppsson JO, Hultberg BL (1988) Folic acid\u2014an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest 48(3):215\u2013221. \n                    https:\/\/doi.org\/10.3109\/00365518809167487","journal-title":"Scand J Clin Lab Invest"},{"issue":"8","key":"3776_CR43","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1111\/febs.12764","volume":"281","author":"N Lin","year":"2014","unstructured":"Lin N, Qin S, Luo S, Cui S, Huang G, Zhang X (2014) Homocysteine induces cytotoxicity and proliferation inhibition in neural stem cells via DNA methylation in vitro. FEBS J 281(8):2088\u20132096. \n                    https:\/\/doi.org\/10.1111\/febs.12764","journal-title":"FEBS J"},{"issue":"6","key":"3776_CR44","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/03630269.2016.1275677","volume":"40","author":"M Garc\u00eda-Morin","year":"2016","unstructured":"Garc\u00eda-Morin M, L\u00f3pez-Sang\u00fcos C, V\u00e1zquez P, Alv\u00e1rez T, Mara\u00f1\u00f3n R, Huerta J, Cela E (2016) Lactate dehydrogenase: a marker of the severity of vaso-occlusive crisis in children with sickle cell disease presenting at the emergency department. Hemoglobin. 40(6):388\u2013391","journal-title":"Hemoglobin."},{"issue":"3","key":"3776_CR45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000328416","volume":"126","author":"OA Najim","year":"2011","unstructured":"Najim OA, Hassan MK (2011) Lactate dehydrogenase and severity of pain in children with sickle cell disease. Acta Haematol 126(3):157\u2013162","journal-title":"Acta Haematol"},{"issue":"2","key":"3776_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/ajcp\/52.2.167","volume":"52","author":"CL Neely","year":"1969","unstructured":"Neely CL, Wajima T, Kraus AP, Diggs LW, Barreras L (1969) Lactic acid dehydrogenase activity and plasma hemoglobin elevations in sickle cell disease. Am J Clin Pathol 52(2):167\u2013169","journal-title":"Am J Clin Pathol"},{"issue":"18","key":"3776_CR47","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.clinbiochem.2012.07.114","volume":"45","author":"KS Stojanovic","year":"2012","unstructured":"Stojanovic KS, Steichen O, Lefevre G, Bachmeyer C, Avellino V, Grateau G et al (2012) High lactate dehydrogenase levels at admission for painful vaso-occlusive crisis is associated with severe outcome in adult SCA patients. Clin Biochem 45(18):1578\u20131582","journal-title":"Clin Biochem"},{"issue":"12","key":"3776_CR48","first-page":"342","volume":"40","author":"A Ojuawo","year":"1994","unstructured":"Ojuawo A, Adedoyin MA, Fagbule D (1994) Hepatic function tests in children with sickle cell anaemia during vaso occlusive crisis. Cent Afr J Med 40(12):342\u2013345","journal-title":"Cent Afr J Med"},{"issue":"13","key":"3776_CR49","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1096\/fasebj.11.13.9367351","volume":"11","author":"P Durand","year":"1997","unstructured":"Durand P, Lussier-Cacan S, Blache D (1997) Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB J 11(13):1157\u20131168","journal-title":"FASEB J"},{"issue":"1","key":"3776_CR50","first-page":"17","volume":"14","author":"J Westwick","year":"1983","unstructured":"Westwick J, Watson-Williams EJ, Krishnamurthi S, Marks G, Ellis V, Scully MF et al (1983) Platelet activation during steady state sickle cell disease. J Med 14(1):17\u201336","journal-title":"J Med"},{"issue":"10","key":"3776_CR51","doi-asserted-by":"publisher","first-page":"E206","DOI":"10.1002\/ajh.24126","volume":"90","author":"K Gardner","year":"2015","unstructured":"Gardner K, Thein SL (2015) Super-elevated LDH and thrombocytopenia are markers of a severe subtype of vaso-occlusive crisis in sickle cell disease. Am J Hematol 90(10):E206\u2013E207","journal-title":"Am J Hematol"},{"issue":"8","key":"3776_CR52","doi-asserted-by":"publisher","first-page":"e0133116","DOI":"10.1371\/journal.pone.0133116","volume":"10","author":"SA Curtis","year":"2015","unstructured":"Curtis SA, Danda N, Etzion Z, Cohen HW, Billett HH (2015) Elevated steady state WBC and platelet counts are associated with frequent emergency room use in adults with sickle cell anemia. PLoS One 10(8):e0133116. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0133116","journal-title":"PLoS One"},{"key":"3776_CR53","doi-asserted-by":"publisher","unstructured":"Brzoska T, Kato GJ, Sundd P (2019) The role of platelets in sickle cell disease. InPlatelets, 4th edn, pp 563\u2013580. \n                    https:\/\/doi.org\/10.1016\/B978-0-12-813456-6.00031-X","DOI":"10.1016\/B978-0-12-813456-6.00031-X"},{"issue":"12","key":"3776_CR54","doi-asserted-by":"publisher","first-page":"E228","DOI":"10.1002\/ajh.24214","volume":"90","author":"CH Alhandalous","year":"2015","unstructured":"Alhandalous CH, Han J, Hsu L, Gowhari M, Hassan J, Molokie R, Abbasi TA, Gordeuk VR (2015) Platelets decline during Vasoocclusive crisis as a predictor of acute chest syndrome in sickle cell disease. Am J Hematol 90(12):E228\u2013E229","journal-title":"Am J Hematol"},{"issue":"7","key":"3776_CR55","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1161\/01.STR.0000169946.31639.af","volume":"36","author":"S Cronin","year":"2005","unstructured":"Cronin S, Furie KL, Kelly PJ (2005) Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke 36(7):1581\u20131587. \n                    https:\/\/doi.org\/10.1161\/01.STR.0000169946.31639.af","journal-title":"Stroke"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03776-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-019-03776-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03776-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T23:10:52Z","timestamp":1597965052000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-019-03776-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["3776"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03776-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"assertion":[{"value":"11 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional ethical committee of VIMSAR, Burla, Odisha (VIREC-No.2016\/I-F-CT-01\/008) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed written consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no financial relationship with the organization that sponsored for the research work. The funding agencies had no involvement in study design, data collection, data analysis, and data interpretation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial relationship"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}